Development of micellar electrokinetic chromatography method for the determination of three defined impurities in indomethacin
- 17 April 2018
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 39 (20) , 2550-2557
Abstract
A micellar electrokinetic chromatography method for the determination of indomethacin impurities (4‐chlorobenzoic acid, 5‐methoxy‐2‐methyl‐3‐indoleacetic acid, and 3,4‐dichloroindomethacin) has been developed. A 64.5/56‐cm fused silica 50 μm id capillary with extended light path (150 μm id) detection window was used. Internal standard was 1‐naphthylacetic acid. The analytes were separated at 30 kV with DAD detection at 224 nm. A central composite face‐centered design was applied for the optimization of the separation conditions. The effect of SDS concentration, content of methanol, concentration of phosphate buffer, and pH of the buffer were studied at three levels. The optimized background electrolyte was 20 mmol/L phosphate buffer (pH 7.57) containing 58 mmol/L SDS and 0% MeOH. Sufficient resolution of all compounds with Rs ≥ 3.5 was achieved within 10 min. The method was validated for a range of 1.25–80 μg/mL of each impurity corresponding to 0.05–3.2% relative to the concentration of indomethacin (2.5 mg/mL). The calibration curves were rectilinear with correlation coefficients r2 exceeding 0.9994. The lower limit of quantification was 0.05% or 1.25 μg/mL that complies with the reporting limits regarding the ICH Q3A guideline. The method was applied to purity assay of indomethacin in both bulk drug and gel.Keywords
Funding Information
- European Regional Development Fund
This publication has 14 references indexed in Scilit:
- Experimental design and multiple response optimization. Using the desirability function in analytical methods developmentTalanta, 2014
- Simple automated generation of gradient elution conditions in sequential injection chromatography using monolithic columnTalanta, 2011
- Application of monolithic columns in pharmaceutical analysis. Determination of indomethacin and its degradation productsJournal of Separation Science, 2009
- Combination of solid‐phase extraction and large‐volume stacking with polarity switching in micellar electrokinetic capillary chromatography for the determination of traces of nonsteroidal anti‐inflammatory drugs in salivaElectrophoresis, 2008
- Development and validation of a capillary electrophoresis method for the simultaneous determination of impurities of escitalopram including the R-enantiomerJournal of Pharmaceutical and Biomedical Analysis, 2008
- Determination of indomethacin in plasma by micellar electrokinetic chromatography with UV detection for premature infants with patent ducts arteriosusJournal of Chromatography B, 2006
- Development and validation of HPLC method for determination of indomethacin and its two degradation products in topical gelJournal of Pharmaceutical and Biomedical Analysis, 2005
- Capillary zone electrophoresis for simultaneous determination of seven nonsteroidal anti-inflammatory drugs in pharmaceuticalsAnalytical and Bioanalytical Chemistry, 2005
- Determination of nonsteroidal anti‐inflammatory drugs in human specimens by capillary zone electrophoresis and micellar electrokinetic chromatographyElectrophoresis, 2004
- Separation of nonsteroidal anti-inflammatory drugs by capillary electrophoresis using nonaqueous electrolytesElectrophoresis, 1999